Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multiple sclerosis and depression].

M P Sánchez López1, T Olivares Pérez, A Nieto Barco

  • 1Universidad de la Laguna, Facultad de Psicologia, La Laguna, España.

Revista De Neurologia
|April 1, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relevance of serum neurofilament light chain determination as a biomarker in multiple sclerosis. Consensus of the Spanish Society of Neurology's Study Group on Multiple Sclerosis and Related Neuroimmune Diseases.

Neurologia·2026
Same author

Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023.

Neurologia·2024
Same author

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

Neurologia·2022
Same author

Knowledge and beliefs about dementia among the general public: A preliminary report on the Cuban population.

Neurologia·2021
Same author

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

Neurologia·2020
Same author

[Specific neurology emergency training of medical residents in Spain].

Neurologia (Barcelona, Spain)·2010
Same journal

The Correlation Between and Variability of Three Balance Scales in the Assessment of Balance Function in Patients With Ataxia.

Revista de neurologia·2026
Same journal

Surgical Treatment of an Aneurysm in the Subacute Stage of Hemorrhagic Moyamoya Disease: Aneurysm Resection Combined With STA-MCA Bypass: A Case Report.

Revista de neurologia·2026
Same journal

Mapping the Evidence: Central Sleep Apnea Syndromes During Sleep and Stroke-A Scoping Review.

Revista de neurologia·2026
Same journal

Developmental and Epileptic Encephalopathy Due to a Novel <i>ARHGEF9</i> Deletion Variant: Case Series of Two Siblings.

Revista de neurologia·2026
Same journal

P300 Event-Related Potentials as Cognitive Biomarkers in Neurological and Neuropsychiatric Disorders: A Systematic Review.

Revista de neurologia·2026
Same journal

[Effectiveness and Risk of Recurrence of Pulsed Radiofrequency in Trigeminal Neuralgia and Chronic Cluster Headache].

Revista de neurologia·2026
See all related articles

This study found that patients with multiple sclerosis experienced minimal depression, which improved after one year of immunomodulatory therapy. Emotional state was linked to cognitive processing speed, not physical disability.

Area of Science:

  • Neurology
  • Immunology
  • Psychiatry

Context:

  • Depression is common in multiple sclerosis (MS), but prevalence rates are affected by study limitations.
  • Depression in MS is linked to diagnosis, physical/cognitive deficits, neural damage, and immunomodulatory treatments.

Purpose:

  • To evaluate the emotional state's progression in relapsing-remitting MS patients with minimal disability.
  • To examine the relationship between emotional state, motor/cognitive slowness, and treatment.

Summary:

  • 35 relapsing-remitting MS patients (27 on interferon, 8 not) were assessed for mood (Beck Depression Inventory), disability (EDSS), and processing speed.
  • Assessments occurred pre-treatment and one year later.
  • Patients showed minimal depression, with scores related to performance difficulties and somatic symptoms, not physical disability.

Related Experiment Videos

Impact:

  • A significant improvement in depression was observed after one year of immunomodulatory therapy.
  • Emotional state in MS is associated with information processing speed, suggesting cognitive factors are crucial.
  • Findings highlight the potential benefits of immunomodulatory therapy for mood disturbances in MS.